Sir Peter MacCallum Department of Oncology - Research Publications

Permanent URI for this collection

Search Results

Now showing 1 - 1 of 1
  • Item
    Thumbnail Image
    BRAF-targeted therapy and immune responses to melanoma
    Ngiow, SF ; Knight, DA ; Ribas, A ; McArthur, GA ; Smyth, MJ (LANDES BIOSCIENCE, 2013-06-01)
    Type I BRAF inhibitors and immunotherapy constitute two new exciting approaches for the treatment of advanced malignant melanoma. We have recently elucidated a role for host C-C chemokine receptor type 2 (CCR2) in the antineoplastic effects of type I BRAF inhibitors in mice, supporting the therapeutic potential of combining BRAF inhibitors with immunotherapy.